6 withdrawn. 6 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Withdrawn 6 |
| Phase 2 | 3 | Withdrawn 3 |
Follow Deficiency Diseases: new trials by email Literature Review of Deficiency Diseases trials Research Report on Deficiency Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) Cannabis oil, Placebo/ Regular Oil - Protein-Energy Malnutrition, Hemodialysis | Phase 3 | Withdrawn | Assaf-Harofeh Medical Center | 2018-09-15 | 2021-07-28 | |
| Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures. Blood draw pre-operatively, Blood draw post-operative Day 1, Blood draw post-operative Day 2 - Vitamin d Deficiency | Phase 3 | Withdrawn | University of Missouri, Kansas City | 2016-02-01 | 2017-06-16 | |
| Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D Placebo, Vitamin D3 - Primary Hyperparathyroidism, Hypercalcemia | Phase 2 / Phase 3 | Withdrawn | Columbia University | 2010-05-01 | 2015-03-05 | |
| The Effect of Vitamin D on Urinary Calcium Excretion in Kidney Stone Formers With High Urinary Calcium vitamin D (ergocalciferol) - Vitamin D Deficiency, Nephrolithiasis | Phase 2 / Phase 3 | Withdrawn | Brigham and Women's Hospital | 2009-08-01 | 2017-01-09 | |
| Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis cholecalciferol - Cystic Fibrosis, Vitamin D Deficiency | Phase 3 | Withdrawn | Children's Hospital of Philadelphia | 2008-03-01 | 2010-02-22 | |
| Penicillamine Chelation for Children With Lead Poisoning d-penicillamine, placebo - Lead Poisoning, Vitamin D Deficiency | Phase 2 / Phase 3 | Withdrawn | FDA Office of Orphan Products Development | 2007-09-01 | 2015-03-26 |
Vitamin D Deficiency (5) · Inflammation (2) · Bone Diseases, Metabolic (1) · Cystic Fibrosis (1) · Feeding and Eating Disorders (1) · Hypercalcemia (1) · Hyperparathyroidism, Primary (1) · Lead Poisoning (1) · Malnutrition (1) · Muscle Cramp (1) · Nephrolithiasis (1) · Osteoporosis (1) · Protein-Energy Malnutrition (1)
Nutrition Disorders (6) · Nutritional and Metabolic Diseases (6) · Avitaminosis (5) · Malnutrition (5) · Pathological Conditions, Signs and Symptoms (3) · Musculoskeletal Diseases (2) · Pathologic Processes (2) · Signs and Symptoms (2) · Bone Diseases (1) · Calcium Metabolism Disorders (1) · Chemically-Induced Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Endocrine System Diseases (1)
Cholecalciferol (2) · Ergocalciferols (1) · Phlebotomy (1) · nabiximols (1)
Assaf-Harofeh Medical Center (1) · Brigham and Women's Hospital (1) · Children's Hospital of Philadelphia (1) · Columbia University (1) · FDA Office of Orphan Products Development (1) · University of Missouri, Kansas City (1)
United States (4) · Israel (1)
Andrea Kelly, MD (1) · Dustin Neel, MD (1) · Jie Tang, M.D., M.Sc (1) · Michael W Shannon, MD (1) · Shonni J. Silverberg, MD (1)
R01DK084986 (1)